A 3D-QSAR of pyridinone binding at the non-nucleoside binding site of HIV-1 reverse transcriptase: A hydropathic molecular dynamics approach.

被引：0
|
作者：
McGrath, CF
Tawa, GJ
Luke, BT
Kellogg, GE
Zaharevitz, DW
Pattabiraman, N
Gussio, R
机构：
[1] VCU, MCV, Richmond, VA 23284 USA
[2] NCI, AVP, SAIC, FBSC, Frederick, MD 21702 USA
[3] NCI, TSBDDG, ITB, DTP, Frederick, MD 21702 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
085-COMP
引用
收藏
页码：U708 / U708
页数：1
相关论文
共 50 条
  • [41] HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors.
    Spence, RA
    Johnson, KA
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : MP356 - MP356
  • [42] Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Famiglini, Valeria
    Silvestri, Romano
    MOLECULES, 2016, 21 (02):
  • [43] Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase
    Carlsson, Jens
    Boukharta, Lars
    Aqvist, Johan
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) : 2648 - 2656
  • [44] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [45] Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Han, Xin
    Wu, Haoming
    Dong, Chune
    Tien, Po
    Xie, Wei
    Wu, Shuwen
    Zhou, Hai-Bing
    RSC ADVANCES, 2015, 5 (13): : 10005 - 10013
  • [46] Ligand based 3D-QSAR modelling studies on 2-amino-6-aryl sulfonylbenzonitriles (AASBNs) as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Sapre, Nitin S.
    Jain , Nilanjana
    Gupta, Swagata
    Sapre, Neelima
    RSC ADVANCES, 2013, 3 (26): : 10442 - 10451
  • [47] Molecular modeling studies of dihydro-alkyloxy-benzyl-oxopyrimidines (DABOs) as non-nucleoside inhibitors of HIV-1 reverse transcriptase using 3D-QSAR, Topomer CoMFA and molecular docking simulations
    Dong, Minghui
    Ren, Yujie
    RSC ADVANCES, 2015, 5 (18): : 13754 - 13761
  • [48] 3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase
    Latha, Ramaswamy Sree
    Vijayaraj, Ramadoss
    Singam, Ettayapuram Ramaprasad Azhagiya
    Chitra, Krishnaswamy
    Subramanian, Venkatesan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (03) : 418 - 426
  • [49] Molecular docking and quantitative structure–activity relationship (QSAR) analyses of indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Vijay H. Masand
    Devidas T. Mahajan
    Taibi Ben Hadda
    Rahul D. Jawarkar
    Hemant Chavan
    B. P. Bandgar
    Harsh Chauhan
    Medicinal Chemistry Research, 2014, 23 : 417 - 425
  • [50] Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase
    D'Cruz, Osmond J.
    Uckun, Fatih M.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (04) : 329 - 350
12345